Event date unknownEvent location unknownChatGPT (reported)
A content creator and singer said in an Instagram video in June 2026 that, during a flare-up of dermatitis brought on by stress and anxiety, they asked ChatGPT for a solution and it said a cream would help clear the dermatitis quickly. The influencer bought the cream at a pharmacy, applied it without consulting a doctor, and showed red, burned-looking skin on the forehead, cheekbones and nose, saying 'my face burned' and that they wanted to cry. The influencer said they had later realised the cream was dangerous for the face and stopped using it, and urged followers to consult health professionals. A day later the influencer reported slow improvement with professional help and a visit to a dermatologist, and later denied rumours of a lawsuit against ChatGPT. The cream, the exact ChatGPT answer and any medical assessment of the cause are not reported.
Core concern Low reported severity Media Coverage
AI involvement reported · Causal attribution alleged · 4 sources, 1 underlying account · Added 27/10/2026
Dec 2019 to Jul 2020United StatesUnidentified facial recognition system
In a complaint filed in federal court in Pennsylvania on 19 December 2023, the US Federal Trade Commission alleged that the pharmacy chain Rite Aid used facial recognition in its stores to match customers against a database of people it suspected of shoplifting or other wrongdoing, and that staff acted on the match alerts by following, searching, ejecting and publicly accusing customers and by calling the police. The FTC says many alerts were false positives: employees recorded thousands of false-positive alerts between December 2019 and July 2020, staff stopped and searched an 11-year-old girl on a false match, and employees called the police on a Black woman matched to an image of a white woman with blonde hair. Rite Aid agreed to a proposed order barring it from using facial recognition in retail stores for five years, without admitting or denying the allegations.
Contextual tracker case Medium reported severity Regulatory Action
AI involvement reported · Causal attribution alleged · 2 sources, 1 underlying account · Added 22/10/2026
28 Jun 2025EgyptDeepSeek
Clinicians at the University Medical Center Hamburg-Eppendorf report in EULAR Rheumatology Open (published 29 September 2026) a man in his thirties with nearly three decades of unexplained febrile attacks who, in a dialogue with DeepSeek begun on 28 June 2025, saw the model's differential narrow to familial Mediterranean fever (FMF). The authors write that the model repeatedly recommended specialist assessment but also discussed a diagnostic trial of colchicine with specific dosing. Motivated by the hypothesis, he arranged commercial genetic testing and obtained colchicine from a pharmacy in Egypt, starting it without specialist supervision. His attacks stopped, but his alanine aminotransferase rose to 160 U/L and colchicine was paused and later resumed at a lower dose. FMF was confirmed when he presented to the clinic in February 2026. The authors write that the case illustrates how patient-facing models may facilitate recognition of rare autoinflammatory diseases, and that confident diagnostic language combined with actionable treatment advice may also encourage unsupervised testing and self-medication.
Core concern Low reported severity Media Coverage
AI involvement reported · Causal attribution alleged · 1 source · Added 12/10/2026
2 Oct 2026United StatesUnidentified AI phone ordering system
In a public post to r/legaladvice created early on 6 October 2026 (UTC), a person who gives their location as Colorado, United States, writes that their insurer moved their prescription to the specialty pharmacy Accredo. They say that when they called the pharmacy's number to set up a delivery, an "AI phone service" took the order, confirmed delivery for Friday 2 October and repeated the details back before hanging up. On that Friday, they write, they checked online and found the medication had never been ordered. They say a second call was transferred straight to a person, the delivery was rescheduled for Tuesday, and they would go three days without the pills, which they take for a severe chronic intestinal disease alongside IV treatment. They say their doctor was consulted and does not like the gap. The poster also says part of the problem was their own late ordering. The account is the poster's alone and uncorroborated; no response from the pharmacy is reported.
Core concern Low reported severity
AI involvement reported · Causal attribution alleged · 1 source · Added 06/10/2026